America’s Blood Centers, AABB, and the American Red Cross sent a joint letter to the U.S. Food and Drug Administration (FDA) to to request the agency revise guidance to clarify that it is not necessary to defer COVID-19 convalescent plasma (CCP) donors following vaccination if the individual has recovered from infection with the SARS-CoV-2 virus and meets all criteria for CCP donation.
Posted in Letters and Comments